| Over a month ago | ||||
Jefferies analyst Adela… Jefferies analyst Adela Dashian initiated coverage of Vimian with a Buy rating and SEK 42 price target. The analyst states that despite its strong growth prospects and superior margins, the stock has significantly de-rated since the IPO, and is now trading in-line with global animal health peers and at a 20% discount to Nordic peer Swedencare. | ||||
Barclays analyst Blanka… Barclays analyst Blanka Porkolab downgraded Vimian to Equal Weight from Overweight. The analyst cites the company's "poor" execution and lack of near-term catalysts for the downgrade. Vimian's expansion strategy could hinder its ability to execute, Porkolab tells investors in a research note. | ||||
